Pascal Furet
机构: Director and leading scientist at Novartis
每年引用次数
引用次数
引用: 19,664
H-指数: 73
I10-指数 : 191
出版物: 491
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
Stefania SARNO , Erika De MOLINER , Maria RUZZENE , Mario A. PAGANO
Biochemical Journal 374 ( 3) 639 -646
127
2003
Small Molecule Inhibitors of the YAP-TEAD Interaction
P FURET
ChemMedChem 17 e202200303 -e202200303
2022
NOVEL AMIDINO-INDANONE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF S-ADENOSYLMETHIONINE DECARBOXYLASE
J STANEK , G CARAVATTI , J FREI , P FURET
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 206 103 -MEDI
1993
SYNTHESIS, BIOLOGICAL EVALUATION AND NEW BINDING MODEL OF AZOLE-TYPE AROMATASE INHIBITORS
M LANG , C BATZL , P FURET , W BECK
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 202 35 -MEDI
1991
Oxazolidin-2-one compounds and uses thereof as pi3ks inhibitors
Giorgio Caravatti , Clive Mccarthy , Robin Alec Fairhurst , Frédéric Stauffer
21
2013
Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
Andreas Floersheimer , Joseph Schoepfer , Pascal Furet , Keiichi Masuya
27
2005
1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
Frédéric Stauffer , Pascal Furet , Frank Stephan Kalthoff , Christian Ragot
16
2010
2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
Pascal Furet , Johann Zimmermann , Patricia Imbach , Carlos Garcia-Echeverria
6
2001
2-amino-6-anilino-purines and their use as medicaments
Pascal Furet , Jürg Zimmermann , Patricia Imbach , Hans-Georg Capraro
43
2000
Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
Joseph Schoepfer , Paul Manley , Robert Martin Grotzfeld , Pascal Furet
38
2013
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
Andreas Floersheimer , Vito Guagnano , Paul William Manley , Guido Bold
242
2003
Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
Pascal Furet , Diana Graus Porta , Vito Guagnano
15
2012
4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
Paul William Manley , Pascal Furet , Hans-Georg Capraro , Carlos Garcia-Echeverria
142
2002
Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this method
Joseph Schoepfer , Edgar Jacoby , Francesco Hofmann , Pascal Furet
6
2006
Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
Pascal Furet , Christoph Gaul , Eric Vangrevelinghe , Soldermann Carole Pissot
34
2008
1H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS
Frédéric Stauffer , Pascal Furet , Patricia Imbach , Robert Mah
4
2010
DERIVADOS DE QUINOXALIN- Y QUINOLIN-CARBOXAMIDA
Pascal Furet , Diana Graus Porta , Vito Guagnano
2010
Medicinal chemistry efforts towards the identification and development of inhibitors of phosphatidylinositol 3-kinases (PI3Ks) and related protein kinases for cancer treatment
Philipp Holzer , Frederic Stauffer , Pascal Furet , Hans-Georg Capraro
Cancer Research 67 3953 -3953
2
2007
compostos de oxazolidin-2-ona como inibidores de pi3ks, seus usos, e composição farmacêutica
Clive Mccarthy , Frédéric Stauffer , Heinrich Rueeger , Pascal Furet
2020
p53 dynamics vary between tissues and are linked with radiation sensitivity.
Jacob Stewart-Ornstein , Philipp Holzer , Pascal Furet , Joerg Kallen
Nature Communications 12 ( 1) 898 -898
2021